The PoC (Point of Care) is not where it used to be…
19 September In the US, the shift in where care is rendered is practically seismic. Almost overnight it seems (5 years in real world terms), retail clinics have become an important part of primary care and convenience is…
Delivering Value To Our Members – ARMI
17 September 2019 When the Australian Regenerative Medicine Institute at Monash University needed help to boost industry awareness of its work and interact with the growing regenerative medicine sector, the BioMelbourne Network helped with contacts and hosted a…
Cyber Attacks: Why Biotech, Life Sciences & Healthcare organisations fall victim to cybercrime & what you can do about it
16 September 2019 Our industry is under attack – there is no doubt about it! The news of yet another organization falling victim to cybercrime has become a daily occurrence. As long as there is a promise of…
Tractography imaging creates beautiful ‘brainbows’ that are helping doctors treat tumours
12 August 2019 Right now, as you’re reading this, lightning-fast instructions are racing through the fibres of your brain. Regulating your breathing. Keeping your core temperature stable. Comprehending the words on the page. There are thousands of these…
AI Computer Generated Works and Copyright Protection
(posted 6th August 2019) Stephens Lawyers & Consultants have published an article which includes practical guidelines on steps that can be taken by businesses/companies to ensure that their AI generated works are protected by copyright. This is the…
Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2020-21
June 2019 The Independent Hospital Pricing Authority (IHPA) has released its Consultation Paper on the Pricing Framework for Australian Public Hospital Services 2020-21. Read more
Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace
12 June 2019 Australian Biotechnology “REALITIES” : From the Laboratory to the Marketplace Cartherics’ Chairman Bob Moses has over 40 years of executive experience in life science companies. You name it, he’s been there: Eli Lilly, ICI Australia, CSL Limited,…
ASX 100 reaches 30 per cent target but board appointments slow
ASX 200 boards have made substantial progress since 2009 when the percentage of female directors stood at just 8.3%. It now stands at 27.7%. The Australian Institute of…
2017 – A Big Year for Biotech!
Our vision for Victoria is to lead the world in health innovation. Discovering, developing and manufacturing the health technologies that change the world. New drugs, devices, diagnostics, vaccines, therapies and digital products – Victoria is the best place to…
